The News
Daily coverage of the developments shaping health and human services. From policy shifts to program innovations, reports on trends-shaping mental health, addiction treatment, child and family services, autism and I/DD, disability support and long-term care, social services, corrections, juvenile justice, chronic disease management, health care systems, and more-helping leaders make timely, informed decisions.
Filter Options
-
Buprenorphine Availability At Pharmacies Increased More In Rural Counties Than Urban Counties
September 15, 2026A larger share of U.S. retail pharmacies consistently dispensed buprenorphine between 2019 and 2025, with the increase greater in rural counties than urban counties. The percentage of rural pharmacies dispensing buprenorphine for opioid use disorder (OUD) increased from 64.9% in… -
UnitedHealthcare To Eliminate Prior Authorization For 1,700 Codes Starting October 1
September 15, 2026UnitedHealthcare will eliminate approximately 1,700 prior authorization requirements across five lines of business beginning October 1, 2026, representing a 30% reduction in prior authorization requirements for the affected plans. The reductions apply to UnitedHealthcare commercial plans, Medicare Advantage plans, Community… -
GLP-1 Use Among Children Ages 8 To 11 With Obesity Remains Rare, But Is Rising
September 15, 2026GLP-1 prescribing among U.S. children ages 8 to 11 with obesity but without diabetes increased sharply between 2019 and 2026, although use remained uncommon overall. Among more than 3.5 million children included in the study, 20,282, or 0.6%, received a… -
Half Of Adults Starting Semaglutide For Weight Loss Stop Within A Year
September 15, 2026Nearly half of 157,822 adults in Denmark who started semaglutide for weight loss stopped treatment within one year. About 13% had discontinued within three months, rising to 27% at six months, 39% at nine months, and 49% at one year.… -
San Francisco To Rebid More Than $500 Million In Annual Homelessness Service Contracts
September 15, 2026San Francisco plans to competitively rebid more than $500 million in annual homelessness and housing grants and contracts as part of a multi-year effort to establish clearer performance expectations and greater contractor accountability. The San Francisco Department of Homelessness and… -
Maryland Launches Statewide Assisted Outpatient Treatment Program
September 15, 2026Maryland has begun implementing a statewide assisted outpatient treatment (AOT) program that allows civil courts to order community-based mental health treatment for certain adults with severe mental illness (SMI) who have difficulty engaging in voluntary treatment. The launch marks a… -
GLP-1 Prescribing Lags Among Adults With Schizophrenia & Diabetes
September 14, 2026From 2018 through 2024, adults with serious mental illness (SMI) were more likely than adults without SMI to receive a prescription for a glucagon-like peptide-1 Adults with diabetes and schizophrenia were less likely to receive glucagon-like peptide-1 (GLP-1) receptor agonist… -
FDA Selects Four Digital Health Companies For TEMPO Pilot; Two Focus On Behavioral Health
September 14, 2026The U.S. Food and Drug Administration (FDA) selected four health technology companies for its Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot in July and August 2026, including two offering technologies for behavioral health treatment. SonderMind, Inc. and Limbic, Inc. are offering… -
Texas Expanding Community-Based Child Welfare Model Into Central Texas & Austin Area
September 14, 2026Texas is expanding its community-based child welfare model into Central Texas and the Austin area, shifting foster and kinship care placements, case management, purchased services, and reunification services for children and youth in state custody from the Texas Department of… -
GLP-1 Use Associated With Lower Mortality Among Adults With Serious Mental Illness
September 14, 2026Adults with serious mental illness (SMI) who started glucagon-like peptide-1 receptor agonists (GLP-1 RAs) had lower mortality than similar adults with SMI who started sodium-glucose cotransporter-2 (SGLT2) inhibitors, according to a recent study. After one year, mortality risk was 48%…
2993 Results | Page 1 of 300